Life Sciences Business Unit - Sales Representative bei BD: Mitarbeiterbewertung

2,0
5. Juni 2018
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Base salary compensation is adequate.

Kontras

Slow moving. Poorly communicated strategy. Support resources (IT, Benefits, etc) are all very difficult to work with. Heavily bureaucratic and lots of politics. Constant changes to commission structure, territory, and management directives. Product support overwhelmed. Terrible CRM. Virtually no support in learning how to 'navigate the company'. Customers are growing more disenchanted and BD is starting to lose foothold as market leader (cytometry).

Mehr Bewertungen zu BD entdecken

5,0
26. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Inherently valuable products, balanced work life

Kontras

Flat company performance - stock is underperforming

2,0
7. Juli 2026
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Nice cafeteria. That’s about it

Kontras

The culture in NJ has been toxic for over a decade. Backstabbing, arrogance, demeaning behavior is the norm. There is an I in team. Everyone in it for themselves on projects. Never saw anything like it in other companies. And if you’re a female over 45 good luck. Many had been let go for no reason, with bogus excuses. It is all condoned from the top.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle